News Patents and designs 2002

From the EPO Site.

Rome, November 14, 2001

The EPO opposition division dealing with Harvard University's "oncomouse" patent has decided to maintain it in amended form. After a two-day hearing, the division ruled that the patent must be limited to transgenic rodents containing an additional cancer gene.

This decision can be appealed by the patentee or any of the opponents.

go back to News > Patents and Designs
go back to News Main Index